NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 254 filers reported holding NOVAVAX INC in Q4 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $174 | -32.6% | 25,100 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $258 | -99.9% | 25,100 | +105.7% | 0.00% | +100.0% |
| Q3 2022 | $222,000 | -64.6% | 12,200 | 0.0% | 0.00% | -75.0% |
| Q2 2022 | $627,000 | -21.1% | 12,200 | +13.0% | 0.00% | 0.0% |
| Q1 2022 | $795,000 | -54.8% | 10,800 | -12.2% | 0.00% | -55.6% |
| Q4 2021 | $1,760,000 | -33.7% | 12,300 | -3.9% | 0.01% | -35.7% |
| Q3 2021 | $2,654,000 | +2.5% | 12,800 | +4.9% | 0.01% | 0.0% |
| Q2 2021 | $2,590,000 | +26.4% | 12,200 | +8.0% | 0.01% | +16.7% |
| Q1 2021 | $2,049,000 | +62.6% | 11,300 | 0.0% | 0.01% | +50.0% |
| Q4 2020 | $1,260,000 | – | 11,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |